We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $661B Turnover 17.31%
1-Year Est. Return 35.87%
 

UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.

This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+35.87%
3 Year Est. Return
+147.27%
5 Year Est. Return
+174.93%
10 Year Est. Return
+646.65%
AUM
$104B
AUM Growth
+$704M
Cap. Flow
-$915M
Cap. Flow %
-0.88%
Top 10 Hldgs %
14.25%
Holding
2,771
New
148
Increased
1,779
Reduced
566
Closed
77
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$191M
2
SCHW icon
Charles Schwab
SCHW
+$157M
3
PFE icon
Pfizer
PFE
+$139M
4
MMM icon
3M
MMM
+$131M
5
META icon
Meta Platforms (Facebook)
META
+$106M

Top Sells

Rank Stock Value
1
ALTR icon
Altera Corp
ALTR
+$288M
2
ICE icon
Intercontinental Exchange
ICE
+$247M
3
RKT icon
Rock-Tenn
RKT
+$142M
4
YELP icon
Yelp
YELP
+$140M
5
CRM icon
Salesforce
CRM
+$135M

Sector Composition

Rank Sector Weight
1 Healthcare 17.79%
2 Financials 14.75%
3 Technology 14.49%
4 Consumer Discretionary 9.64%
5 Industrials 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.12T
$3.86B 3.7%
123,235,912
-3,769,028
-3% -$121M
2013 Q2
8 quarters
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.45T
$1.82B 1.75%
68,744,740
+1,088,117
+2% +$29.2M
2013 Q2
8 quarters
MSFT icon
3
Microsoft
MSFT
$3.77T
$1.47B 1.41%
33,276,333
-893,495
-3% -$40.8M
2013 Q2
8 quarters
XOM icon
4
ExxonMobil
XOM
$657B
$1.28B 1.22%
15,359,193
+199,868
+1% +$17.2M
2013 Q2
8 quarters
META icon
5
Meta Platforms (Facebook)
META
$1.57T
$1.2B 1.15%
13,958,040
+1,299,154
+10% +$106M
2013 Q2
8 quarters
GILD icon
6
Gilead Sciences
GILD
$209B
$1.13B 1.08%
9,663,533
-264,416
-3% -$28.9M
2013 Q2
8 quarters
WFC icon
7
Wells Fargo
WFC
$244B
$1.08B 1.03%
19,188,910
-304,809
-2% -$17M
2013 Q2
8 quarters
JNJ icon
8
Johnson & Johnson
JNJ
$657B
$1.06B 1.02%
10,885,113
+61,446
+0.6% +$6.15M
2013 Q2
8 quarters
GE icon
9
GE Aerospace
GE
$341B
$1.02B 0.97%
7,988,609
-619,968
-7% -$80.4M
2013 Q2
8 quarters
JPM icon
10
JPMorgan Chase
JPM
$862B
$966M 0.92%
14,249,684
-204,302
-1% -$13.3M
2013 Q2
8 quarters
AMZN icon
11
Amazon
AMZN
$2.89T
$929M 0.89%
42,812,200
-5,594,840
-12% -$117M
2013 Q2
8 quarters
C icon
12
Citigroup
C
$195B
$918M 0.88%
16,622,747
+634,912
+4% +$34.5M
2013 Q2
8 quarters
PFE icon
13
Pfizer
PFE
$160B
$909M 0.87%
28,568,618
+4,266,856
+18% +$139M
2013 Q2
8 quarters
CELG
14
DELISTED
Celgene
CELG
$871M 0.83%
7,524,780
-250,680
-3% -$28.7M
2013 Q2
8 quarters
HD icon
15
Home Depot
HD
$338B
$851M 0.81%
7,655,969
+16,659
+0.2% +$1.87M
2013 Q2
8 quarters
AGN
16
DELISTED
Allergan plc
AGN
$839M 0.8%
2,765,665
+639,106
+30% +$191M
2013 Q2
8 quarters
V icon
17
Visa
V
$776B
$829M 0.79%
12,341,609
+199,710
+2% +$13.5M
2013 Q2
8 quarters
CVX icon
18
Chevron
CVX
$403B
$789M 0.76%
8,174,499
+73,387
+0.9% +$7.71M
2013 Q2
8 quarters
PG icon
19
Procter & Gamble
PG
$394B
$781M 0.75%
9,988,290
+99,424
+1% +$8M
2013 Q2
8 quarters
PEP icon
20
PepsiCo
PEP
$193B
$759M 0.73%
8,132,421
-88,611
-1% -$8.47M
2013 Q2
8 quarters
DIS icon
21
Walt Disney
DIS
$211B
$749M 0.72%
6,564,815
+104,016
+2% +$11.4M
2013 Q2
8 quarters
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.22T
$743M 0.71%
5,458,354
+83,575
+2% +$11.9M
2013 Q2
8 quarters
BAC icon
23
Bank of America
BAC
$337B
$734M 0.7%
43,146,740
-738,442
-2% -$12.2M
2013 Q2
8 quarters
T icon
24
AT&T
T
$149B
$703M 0.67%
26,195,606
-476,776
-2% -$12.3M
2013 Q2
8 quarters
CMCSA icon
25
Comcast
CMCSA
$90.2B
$674M 0.65%
22,414,146
+1,442,954
+7% +$42.4M
2013 Q2
8 quarters

Similar funds

UBS AM's Q2 2015 Portfolio in Review

As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
  • UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
  • UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
  • UBS AM fully exited Pharmacyclics in Q2 2015, selling an estimated $78.3M.
  • UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
  • UBS AM opened 148 new positions and closed 77 in Q2 2015.
  • UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.

Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.